Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > PA Providers

Dr. Marc A. Lavine, MD, FACS

Accepting New Patients

(13544 Ratings)

Specializes in: Urologic Oncology

Temple University School of Medicine

Professional interests include: robotic prostatectomy, vasectomy, urologic (genitourinary) disorders, and more.

240 Middletown Boulevard
Langhorne, PA 19047

(215) 632-8882

Dr. Marc A. Lavine, MD, FACS is an urologic oncologist in Langhorne, PA specializing in urologic oncology. He graduated from Temple University School of Medicine. Dr. Marc A. Lavine, MD, FACS is affiliated with Jefferson Health, Temple Health, Jefferson Torresdale Hospital, Jefferson Bucks Hospital and Jefferson Frankford Hospital.

Office Locations

Jefferson Frankford Hospital

240 Middletown Boulevard
Langhorne, PA 19047

(215) 741-1231

open_in_new

Temple Health

3998 Red Lion Road Suite 305
Philadelphia, PA 19114

(215) 632-8882

open_in_new

Some issues Dr. Marc A. Lavine, MD, FACS can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

Shock Wave Lithotripsy

Stones are formed when mineral deposits build up and harden in an organ or gland. For example, urine contains minerals that can form crystals and result in kidney or bladder stones. Stones can also occur in other parts of the body, like the mouth. Salivary gland stones form when the chemicals in the saliva harden and get stuck in the tiny ducts of the salivary glands. Pain and swelling are the most common symptoms associated with stones.

Lithotripsy is a procedure used to break up small stones. Shock wave lithotripsy, the most common type of lithotripsy and least invasive way of treating stones, does this using high-powered sound waves. This procedure can treat many types of stones in the body, but it is most frequently used for urinary stones, such as kidney and bladder stones.

Shock wave lithotripsy can be done in one of two ways. Conventionally, this procedure is performed when someone is sitting in a tub of water, and the sound waves travel through the water to their body. A more recent alternative is to send the shock waves through cushions while a patient is lying on a table. Although shock wave lithotripsy is not surgery and requires no cutting, the patient will be given anesthesia before the procedure. Their body should be able to pass the broken-up urinary stones naturally in their urine after treatment. For other types of stones, another minimally invasive procedure may be required to remove stone fragments left by shock wave lithotripsy.

Noteworthy Medicare Patient Procedures Performed by Dr. Marc A. Lavine, MD, FACS in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

biopsy

core needle prostate biopsy

cystoscopy with bladder biopsy

indwelling urethral catheter insertion

prostate biopsy

prostate punch biopsy

By Affordability:

bladder biopsy

cystoscopy with bladder biopsy

In 2023, among providers in related specialties within Pennsylvania, Dr. Marc A. Lavine, MD, FACS performed more biopsy, core needle prostate biopsy, cystoscopy with bladder biopsy, indwelling urethral catheter insertion, prostate biopsy, and prostate punch biopsy procedures for Medicare patients than 95% of them and he also had a list price for bladder biopsy, and cystoscopy with bladder biopsy that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Volume:

inpatient hospital care

percutaneous procedures

urinalysis

By Affordability:

hospital care

inpatient care

inpatient hospital care

In 2023, among providers in related specialties within Pennsylvania, Dr. Marc A. Lavine, MD, FACS performed more inpatient hospital care (for patient admitted to hospital), percutaneous procedures, and urinalysis procedures for Medicare patients than 90% of them and he also had a list price for hospital care, inpatient care, and inpatient hospital care (for patient admitted to hospital) that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

urologic procedures

By Affordability:

core needle prostate biopsy

lab tests

prostate biopsy

prostate punch biopsy

urinalysis

urine tests

In 2012, among providers in related specialties within Pennsylvania, Dr. Marc A. Lavine, MD, FACS performed more urologic procedures procedures for Medicare patients than 75% of them and he also had a list price for core needle prostate biopsy, lab tests, prostate biopsy, prostate punch biopsy, urinalysis, and urine tests that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2012 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	57
doctor visit	748
hospital care	512
inpatient care	512
lab tests	708
lithotripsy (stone fragmentation)	42
minimally invasive procedures	126
stent placement (stenting)	44
urologic procedures	293

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2013 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	58
doctor visit	686
hospital care	371
inpatient care	371
lab tests	664
laser treatment	12
lithotripsy (stone fragmentation)	61
minimally invasive procedures	149
stent placement (stenting)	51
urologic procedures	307

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	532
Female	189

**Ethnicity**
Non-Hispanic White	621
Black	44
Hispanic	23
Asian	17
Other	16
Native American	0

**Age**
From 65 to 74	337
From 75 to 84	150
85 and over	91
Less than 65	143

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2013

Hypertension	75
High Cholesterol	70
Stroke	11
Ischemic Heart Disease	54
Depression	25
Chronic Kidney Disease	44
Asthma	6
Osteoperosis	5
Atrial Fibrilation	18
Heart Failure	26
Chronic Obstructive Pulmonary Disease	23
Diabetes	42
Dementia	16
Cancer	16

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2014 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	69
doctor visit	708
foreign body removal	17
hospital care	376
inpatient care	376
lab tests	650
laser treatment	15
lithotripsy (stone fragmentation)	58
minimally invasive procedures	159
stent placement (stenting)	54
urologic procedures	318

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	534
Female	205

**Ethnicity**
Non-Hispanic White	629
Black	48
Hispanic	33
Asian	14
Other	15
Native American	0

**Age**
From 65 to 74	316
From 75 to 84	158
85 and over	103
Less than 65	162

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2014

Hypertension	75
High Cholesterol	71
Stroke	10
Ischemic Heart Disease	53
Depression	29
Chronic Kidney Disease	46
Asthma	8
Osteoperosis	6
Atrial Fibrilation	18
Heart Failure	28
Chronic Obstructive Pulmonary Disease	24
Diabetes	46
Dementia	18
Cancer	17

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2015 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	70
doctor visit	755
hospital care	326
inpatient care	326
lab tests	621
laser treatment	11
lithotripsy (stone fragmentation)	47
minimally invasive procedures	140
stent placement (stenting)	44
urologic procedures	320

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	1044
Female	396

**Ethnicity**
Non-Hispanic White	1218
Black	94
Hispanic	46
Asian	38
Other	44
Native American	0

**Age**
From 65 to 74	660
From 75 to 84	348
85 and over	162
Less than 65	270

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2015

Hypertension	75
High Cholesterol	75
Stroke	11
Ischemic Heart Disease	52
Depression	28
Chronic Kidney Disease	48
Asthma	15
Osteoperosis	7
Atrial Fibrilation	20
Heart Failure	28
Chronic Obstructive Pulmonary Disease	23
Diabetes	47
Dementia	18
Cancer	17

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2016 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	68
doctor visit	750
foreign body removal	20
hospital care	342
inpatient care	342
lab tests	623
laser treatment	15
lithotripsy (stone fragmentation)	53
minimally invasive procedures	150
stent placement (stenting)	40
urologic procedures	332

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	552
Female	195

**Ethnicity**
Non-Hispanic White	658
Black	37
Hispanic	22
Asian	15
Other	15
Native American	0

**Age**
From 65 to 74	336
From 75 to 84	195
85 and over	91
Less than 65	125

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2016

Hypertension	75
High Cholesterol	72
Stroke	10
Ischemic Heart Disease	52
Depression	29
Chronic Kidney Disease	55
Asthma	21
Osteoperosis	6
Atrial Fibrilation	20
Heart Failure	27
Chronic Obstructive Pulmonary Disease	20
Diabetes	45
Dementia	17
Cancer	16

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2017 were lab tests, urologic procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	76
doctor visit	773
foreign body removal	16
hormone therapy	20
hospital care	291
inpatient care	291
lab tests	626
laser treatment	17
lithotripsy (stone fragmentation)	45
minimally invasive procedures	140
stent placement (stenting)	52
urologic procedures	313

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	546
Female	178

**Ethnicity**
Non-Hispanic White	632
Black	36
Hispanic	21
Asian	19
Other	16
Native American	0

**Age**
From 65 to 74	341
From 75 to 84	176
85 and over	76
Less than 65	131

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2017

Hypertension	75
High Cholesterol	67
Stroke	10
Ischemic Heart Disease	48
Depression	26
Chronic Kidney Disease	54
Asthma	7
Osteoperosis	5
Atrial Fibrilation	18
Heart Failure	25
Chronic Obstructive Pulmonary Disease	18
Diabetes	45
Dementia	17
Cancer	17

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2018 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

diagnostic procedures	15
doctor visit	781
foreign body removal	11
hormone therapy	17
hospital care	342
inpatient care	342
lab tests	656
laser treatment	17
lithotripsy (stone fragmentation)	37
minimally invasive procedures	139
stent placement (stenting)	45
urologic procedures	225

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	606
Female	186

**Ethnicity**
Non-Hispanic White	685
Black	44
Hispanic	24
Asian	20
Other	19
Native American	0

**Age**
From 65 to 74	355
From 75 to 84	207
85 and over	88
Less than 65	142

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2018

Hypertension	75
High Cholesterol	75
Stroke	8
Ischemic Heart Disease	49
Depression	28
Chronic Kidney Disease	58
Asthma	6
Osteoperosis	5
Atrial Fibrilation	20
Heart Failure	24
Chronic Obstructive Pulmonary Disease	21
Diabetes	43
Dementia	18
Cancer	17

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2019 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	47
doctor visit	856
foreign body removal	18
hormone therapy	15
hospital care	327
inpatient care	327
lab tests	739
laser treatment	23
lithotripsy (stone fragmentation)	41
minimally invasive procedures	149
stent placement (stenting)	53
urologic procedures	301

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	621
Female	213

**Ethnicity**
Non-Hispanic White	720
Black	46
Hispanic	31
Asian	13
Other	24
Native American	0

**Age**
From 65 to 74	400
From 75 to 84	210
85 and over	81
Less than 65	143

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2019

Hypertension	75
High Cholesterol	75
Stroke	9
Ischemic Heart Disease	45
Depression	29
Chronic Kidney Disease	52
Asthma	7
Osteoperosis	5
Atrial Fibrilation	18
Heart Failure	21
Chronic Obstructive Pulmonary Disease	18
Diabetes	42
Dementia	13
Cancer	17

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2020 were lab tests, urologic procedures, minimally invasive procedures and inpatient care.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	47
diagnostic procedures	125
doctor visit	846
foreign body removal	12
hormone therapy	25
hospital care	269
inpatient care	269
lab tests	505
laser treatment	19
lithotripsy (stone fragmentation)	19
minimally invasive procedures	271
minor procedures	125
stent placement (stenting)	44
urologic procedures	442

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	775
Female	169

**Ethnicity**
Non-Hispanic White	809
Black	49
Hispanic	36
Asian	22
Other	28
Native American	0

**Age**
From 65 to 74	516
From 75 to 84	240
85 and over	63
Less than 65	125

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2020

Hypertension	74
High Cholesterol	73
Stroke	6
Ischemic Heart Disease	44
Depression	22
Chronic Kidney Disease	47
Asthma	6
Osteoperosis	3
Atrial Fibrilation	14
Heart Failure	20
Chronic Obstructive Pulmonary Disease	15
Diabetes	37
Dementia	12
Cancer	24

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2021 were urologic procedures, hospital care, inpatient care and minimally invasive procedures.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	41
diagnostic procedures	113
doctor visit	951
hormone therapy	32
hospital care	310
inpatient care	310
lab tests	118
laser treatment	19
lithotripsy (stone fragmentation)	19
minimally invasive procedures	250
minor procedures	113
stent placement (stenting)	47
urologic procedures	446

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	805
Female	192

**Ethnicity**
Non-Hispanic White	847
Black	55
Hispanic	36
Asian	22
Other	37
Native American	0

**Age**
From 65 to 74	548
From 75 to 84	251
85 and over	73
Less than 65	125

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2021

Hypertension	75
High Cholesterol	75
Stroke	7
Ischemic Heart Disease	43
Depression	22
Chronic Kidney Disease	48
Asthma	7
Osteoperosis	5
Atrial Fibrilation	17
Heart Failure	20
Chronic Obstructive Pulmonary Disease	16
Diabetes	41
Dementia	12
Cancer	22

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA during 2022 were lab tests, urologic procedures, inpatient care and hospital care.

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

catheterization	61
diagnostic procedures	114
doctor visit	1013
hormone therapy	31
hospital care	272
inpatient care	272
lab tests	730
laser treatment	14
lithotripsy (stone fragmentation)	14
marker placement for prostate radiation therapy	14
minimally invasive procedures	217
minor procedures	114
stent placement (stenting)	28
urologic procedures	448

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Male	790
Female	176

**Ethnicity**
Non-Hispanic White	831
Black	55
Hispanic	26
Asian	18
Other	36
Native American	0

**Age**
From 65 to 74	494
From 75 to 84	293
85 and over	67
Less than 65	112

Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS in 2022

Hypertension	75
High Cholesterol	75
Stroke	10
Ischemic Heart Disease	39
Depression	24
Chronic Kidney Disease	31
Asthma	8
Osteoperosis	8
Atrial Fibrilation	23
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	39
Dementia	9
Cancer	26

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Marc A. Lavine, MD, FACS for Medicare patients.

The highest averages for the top procedures that Dr. Marc A. Lavine, MD, FACS treated as an urologic oncologist in Langhorne, PA were lab tests, urologic procedures, inpatient care and hospital care.

catheterization	59
diagnostic procedures	91
doctor visit	806
foreign body removal	15
hormone therapy	23
hospital care	339
inpatient care	339
lab tests	603
laser treatment	16
lithotripsy (stone fragmentation)	39
minimally invasive procedures	171
minor procedures	117
stent placement (stenting)	45
urologic procedures	340

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Marc A. Lavine, MD, FACS.

**Gender**
Female	190
Male	618

**Ethnicity**
Black / African American	46
Asian / Pacific Islander	18
Non-Hispanic White	695
Hispanic	27
Native American / Alaskan Native	0
Other	22

**Age**
85 and over	81
75 to 84	202
Less than 65	134
65 to 74	391

Average of Total of Conditions of Medicare patients treated by Dr. Marc A. Lavine, MD, FACS From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Marc A. Lavine, MD, FACS treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	68
High Cholesterol	66
Stroke	8
Ischemic Heart Disease	43
Depression	23
Chronic Kidney Disease	43
Asthma	8
Osteoporosis	5
Heart Failure	21
Chronic Obstructive Pulmonary Disease	17
Diabetes	38
Atrial Fibrillation	16
Dementia	13
Cancer	17

Education & Training

Dr. Marc A. Lavine, MD, FACS graduated from Temple University School of Medicine. He completed residency at Rhode Island Hospital. He is certified by the American Board of Urology and has a state license in Pennsylvania.

Medical School: Temple University School of Medicine

Residency: Rhode Island Hospital

Board Certification: American Board of Urology

Licensed In: Pennsylvania

Affiliations & Hospitals

Dr. Marc A. Lavine, MD, FACS is associated with these hospitals and organizations:

Jefferson Health

Temple Health

Jefferson Torresdale Hospital

Jefferson Bucks Hospital

Jefferson Frankford Hospital

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Marc A. Lavine, MD, FACS appears to accept the following insurance providers: United Healthcare Community Plan (AmeriChoice), QualCare, Aetna Medicare, Highmark Blue Cross Blue Shield, CIGNA Medicare, Blue Cross Federal, Horizon Blue Cross Blue Shield, GEHA, WellCare, AmeriHealth, AARP, MultiPlan, CIGNA Commercial, Geisinger Health Plan, US Family Health Plan, United Healthcare, Medicaid, Humana, Cigna, Workers' Compensation, Devon Health, TRICARE, First Health, WellPoint, Jefferson Health Plans (Medicare & ACA), Medical Assistance of New Jersey, Provider Partners Medicare, PA Health and Wellness CHC, Devoted Medicare, Medical Assistance of Delaware, Keystone First/CHC/VIP, Blue Card by BCBS, Medicare FFS, Medical Assistance of Pennsylvania, Independence Blue Cross - Various plans, Aetna Commercial - Excludes Marketplace Plans, UPMC, Aetna Better Health CHIP PA, Highmark Wholecare, Ambetter from PA Health and Wellness and Keystone First VIP.

Insurance Accepted by Provider includes:

According to our sources, Dr. Marc A. Lavine, MD, FACS accepts the following insurance providers:

United Healthcare Community Plan (AmeriChoice)

QualCare

Aetna Medicare

Highmark Blue Cross Blue Shield

CIGNA Medicare

Blue Cross Federal

Horizon Blue Cross Blue Shield

GEHA

WellCare

AmeriHealth

AARP

MultiPlan

CIGNA Commercial

Geisinger Health Plan

US Family Health Plan

United Healthcare

Medicaid

Humana

Cigna

Workers' Compensation

Devon Health

TRICARE

First Health

WellPoint

Jefferson Health Plans (Medicare & ACA)

Medical Assistance of New Jersey

Provider Partners Medicare

PA Health and Wellness CHC

Devoted Medicare

Medical Assistance of Delaware

Keystone First/CHC/VIP

Blue Card by BCBS

Medicare FFS

Medical Assistance of Pennsylvania

Independence Blue Cross - Various plans

Aetna Commercial - Excludes Marketplace Plans

UPMC

Aetna Better Health CHIP PA

Highmark Wholecare

Ambetter from PA Health and Wellness

Keystone First VIP

Ratings & Reviews

Dr. Marc A. Lavine, MD, FACS has an exceptional overall rating with an average of 4.9 out of 5 stars based on 13544 ratings. We collect ratings and reviews of Dr. Marc A. Lavine, MD, FACS from all over the web to help you find the right in Langhorne, PA.

4.9

Overall Rating

(13544 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Marc A. Lavine, MD, FACS. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Astellas Pharma US Inc	$1,848 XTANDI $824	Vesicare $527	Myrbetriq $223	$275
Sumitomo Pharma America, Inc.	$390 GEMTESA $322	ORGOVYX $68
UROVANT SCIENCES INC	$381 GEMTESA $381
Janssen Biotech, Inc.	$260 Erleada $170	ZYTIGA $73	$16
AbbVie, Inc.	$248 Lupron $126	Androgel $89	Lupron Depot $33
Other	$2,598 Prolaris $239	GENTLECATH $218	Uribel $152	ORGOVYX $136	CONCERTOTM $132	Other $1,720

**Types of Payments**
Food and Beverage	$5,332
Education	$393

Biography

Dr. Marc Lavine's specialty is urologic oncology. Patients rated Dr. Lavine highly, giving him an average of 5.0 stars (out of 5). These areas are among his clinical interests: uroflowmetry, shock wave lithotripsy, and intravenous pyelogram (IVP). He is professionally affiliated with Temple Health and Aria Health Physician Services. Dr. Lavine can take Blue California, Coventry, Geisinger Health Plan, and more. He welcomes new patients at his office inLanghorne, PA as reported by Jefferson Health. He graduated from Temple University School of Medicine. Dr. Lavine trained at Rhode Island Hospital for residency.